Quick Facts
FONT-SIZE Plus   Neg
Share SHARE
mail  E-MAIL

Mylan Enters Settlement Agreement In Litigation Relating To Its Generic Xopenex

RELATED NEWS
Trade MYL now with 
5/29/2012 8:17 AM ET

Mylan Inc. (MYL: Quote) said Mylan Specialty L.P. has entered into a settlement agreement with Sunovion Pharmaceuticals Inc. that will resolve the parties' patent litigation in connection with Mylan Specialty's ANDA for Levalbuterol Hydrochloride (HCl) Inhalation Solution, 0.31 mg/3 mL, 0.63 mg/3 mL, 1.25 mg/3 mL and 1.25 mg/0.5mL.

Levalbuterol HCl is the generic version of Sunovion's Xopenex product.

As per the terms of the settlement, Mylan Specialty is licensed to continue sales of its concentrate product and will have a royalty-bearing license to sell its non-concentrate product upon receiving final approval from the U.S. Food and Drug Administration. The settlement also releases Mylan from payment of the $18 million jury damage award to Sunovion.

Pursuant to the agreement, pending litigation will be dismissed.

Click here to receive FREE breaking news email alerts for Mylan Inc. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
While selling pressure has remained subdued, stocks continue to see modest weakness in mid-day trading on Wednesday. The losses on the day are partly offsetting the gains posted over the course of the two previous sessions. The major averages have moved to the downside in recent trading, with the Nasdaq hitting a new low for the session. Providing a potential boost to comprehensive immigration reform, the non-partisan Congressional Budget Office has estimated that the immigration bill currently being debated in the Senate would result in a notable reduction to the federal budget deficit. Along a dirt track on an unexpectedly cool and windy night on Jordan's border with Syria, as shadows lengthened across the barren hills, UNHCR Special Envoy Angelina Jolie listened to the stories of men, women and children who had fled Syria just hours before. She heard stories of bombs and pain and loss from people fleeing Homs, Dara'a and Qusair, three of the communities devastated by the Sy
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.